Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New drug submission filed in Canada for metastatic breast cancer treatment
July 14th, 2005
American Pharmaceutical Partners, Inc., (APP) (APPX) said that a new drug submission for ABRAXANE has been filed with the Therapeutic Products Directorate (TPD) of Health Canada. The submission seeks Health Canada's approval to market ABRAXANE in Canada for the treatment of metastatic breast cancer. "We are pleased to be taking this next step toward expanding our marketing of ABRAXANE throughout North America," said APP president and chief executive officer Alan Heller. "We are encouraged by the success we currently are experiencing in the U.S. and are eager to broaden the scope of our efforts to markets such as Canada." "This filing marks yet...
Source: Women's Health Weekly (2005-07-14)
|
